U.S. FDA permitted marketing of first COVID-19 at-home test using traditional premarket review process
On Jun. 6, 2023, the U.S. Food and Drug Administration (FDA) granted granted marketing authorization for the Cue COVID-19…
-
-
U.S. FDA approved ABRYSVO, Pfizer’s vaccine for prevention of RSV in older adults
On May 31, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO (Respiratory…
-
WHO reported Avian influenza A(H5N1) in United Kingdom of Great Britain and Northern Ireland
On May 30, 2023, the United Kingdom of Great Britain and Northern Ireland reported to the World Health…
-
Novavax’s Nuvaxovid received positive CHMP opinion for full marketing authorization for prevention of COVID in the EU
On May 26, 2023, Novavax announced that Nuvaxovid (NVX-CoV2373) had been recommended for full Marketing Authorization (MA) for…
-
U.S. FDA approved Paxlovid, first oral antiviral for treatment of COVID-19 in adults
On May 25, 2023, the U.S. Food and Drug Administration (FDA) approved the oral antiviral Paxlovid (nirmatrelvir tablets…
-
Brazil confirmed first ever avian flu cases in wild birds
On May 15, 2023, Brazil, the world’s top chicken exporter, for the first time confirmed Highly Pathogenic Avian…
-
USDA took action to help protect endangered California Condors from highly pathogenic Avian influenza
On May 12, 2023, the U.S. Departments of Agriculture Animal (USDA) and Plant Health Inspection Service (APHIS) announced…
-
WHO declared end to mpox public health emergency
On May 11, 2023, the World Health Organization announced it was ending a 10-month-long global health emergency for…
-
NIH study identified features of Long COVID neurological symptoms
On May 5, 2023, the National Institutes of Health reported that a study had identified features of Long…
-
World Health Organization ended its declaration of COVID-19 as a global health emergency
On May 5, 2023, the World Health Organization (WHO) ended its declaration of COVID-19 as a global health…
-
World Health Organization reported enterovirus infections in France
On May 5, 2023, France reported nine cases of severe neonatal sepsis associated with hepatic impairment and multi-organ failure…
-
U.S. FDA approved first Respiratory Syncytial Virus (RSV) vaccine
On May 3, 2023, the U.S. FDA approved GlaxoSmithKline’s Arexvy as the first respiratory syncytial virus (RSV) vaccine…
-
U.S. Preventive Services Task Force recommended screening for latent tuberculosis infection
On May 2, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
-
Biotechnology | Clinical Research | Diagnostics | FDA | Infectious Disease | NIH | Therapeutics | Vaccine | Women's Health
U.S. FDA announced additional steps to advance decentralized clinical trials
On May 2, 2023, the U.S. Food and Drug Administration (FDA) announced that it was taking additional steps…
-
Study raised concerns SARS-CoV-2 evolution outpaces vaccine-generated antibodies
On Apr. 27, 2023, a National Institute of Allergy and Infectious Diseases (NIAID) -led Phase 2 trial compared two…
-
U.S. FDA issued Emergency Use Authorization for new COVID-19 Over-the-Counter at-home antigen test
On Apr. 24, 2023, the U.S. Food and Drug Administration (FDA) authorized Status COVID-19 Antigen Rapid Test for…
-
Additional cases of Marburg virus disease reported in Equatorial Guinea
On Apr. 17, 2023, the World Health Organization (WHO) announced that six additional laboratory-confirmed cases of Marburg virus…
-
U.S. spending $5 billion to speed up development of new COVID vaccines
On Apr. 10, 2023, the U.S. Department of Health and Human Services (HHS) announced it was spending over…
-
Infectious Disease | Influenza | USDA | Vaccine | Veterinary
Highly pathogenic avian influenza confirmed as cause of three California condor mortalities in Arizona
On Apr. 7, 2023, the U.S. National Park Service reported Highly Pathogenic Avian Influenza (HPAI) had been confirmed…
-
Defense Public Health celebrated opening of new $248 million public health laboratory
On Apr. 5, 2023, Aberdeen Proving Ground South, formerly known as Edgewood, celebrated the opening of the Department…
-
Pfizer RSV vaccine 82% effective vs severe infection in infants, final data showed
On Apr. 5, 2023, Pfizer announced that experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Therapeutics | Vaccine
Frequent testing reduced COVID-19 deaths in nursing facilities
On Apr. 4, 2023, National Institutes of Health (NIH) funded research was announced from the University of Rochester…
-
NanoViricides announced licensing agreement with Karveer Meditech to commercialize COVID drugs
On Apr. 4, 2023, NanoViricides announced that it had executed a license agreement with Karveer Meditech, Kolhapur, India,…
-
First case of highly pathogenic Avian influenza confirmed in Klamath County
On Mar. 31, 2023, the Oregon Department of Agriculture and the United States Department of Agriculture’s Animal and…
-
Moderna finalized agreement with Government of the Republic of Kenya to establish an mRNA manufacturing facility
On Mar. 30, 2023, Moderna and the Government of the Republic of Kenya announced they had finalized an…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | U.S. Congress | Vaccine
Covid-19 pandemic and the expansion of the mortality gap between the U.S. and its European peers
On Mar. 29, 2023, the mortality gap between the United States and other high-income nations substantially expanded during…
-
Human infection with Avian influenza A(H3N8) virus reported by China
On Mar. 27, 2023, the National Health Commission of the People’s Republic of China reported a confirmed case…
-
Antibiotics do not cut death risk in hospitalized patients with viral respiratory illnesses
On Mar. 24. 2023, antibiotics do not reduce the risk of dying in adults hospitalized with COVID-19, the…
-
Climate warming and increasing Vibrio vulnificus infections in North America
On Mar. 23, 2023, a study published in Scientific Reports warned that vibrio vulnificus is an increasingly recognized…
-
Paxlovid reduced risk of long-term health problems, death from COVID-19
On Mar. 23. 2023, researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs…
